Gate SPECT technology allows evaluation of myocardial perfusion and myocardial segmental viability in patients with chronic ischemic heart disease. Studies evaluating the ability of myocardial perfusion studies to predict clinical outcomes are contradictory in that many have shown ability to predict morbidity and mortality endpoints while others didn't .